Alzheimer's Drug Won't Be Discontinued After All

Actavis announced that it will continue to distribute Namenda (memantine HCI) tablets due to a recent decision by a panel of the U.S. Court of Appeals for the Second Circuit.

Low Doses of CO May Lessen Brain Damage Post-Hemorrhage

Results from a new study suggest that small controlled doses of carbon monoxide may protect the brain from damage after a subarachnoid hemorrhage by speeding up the clearance of heme that accumulates.

Vaccine to Treat Hypertension in the Works

Researchers have created a DNA vaccine that may help reduce blood pressure for up to six months, new research published in the journal Hypertension has shown.

Overweight Male Teens Could Face Greater Bowel Cancer Risk in Future

Very overweight male adolescents could have double the risk of developing bowel cancer later in life compared to those of normal weight, according to new research appearing in the journal Gut.

Evaluating the Efficacy of Loop Diuretics for Primary Hypertension

A review in the Cochrane Library identified nine randomized controlled trials (RCTs) to determine dose-related decreases in systolic and/or diastolic blood pressure among loop diuretics, along with dose-related adverse events.

Lassa Fever Death Confirmed in N.J. Man

On May 25th, the Centers for Disease Control and Prevention (CDC) and the New Jersey Department of Health reported a death due to Lassa fever in a person returning to the United States from Liberia.

Soy Supplements May Not Help Uncontrolled Asthma After All

A new study published in JAMA has found that supplementation with soy isoflavone did not improve lung function or critical outcomes in patients with poor asthma control, despite previous research suggesting that it may be an effective treatment.

Par Launches Cortisporin-TC Otic Suspension

Par announced the launch of Cortisporin-TC (colistin sulfate, neomycin sulfate, thonzonium bromide, hydrocortisone acetate) Otic Suspension for the treatment of otitis externa caused by susceptible organisms and for the treatment of mastoidectomy and fenestration cavities caused by susceptible organisms.

Patients at Highest Risk for Fractures Often Miss Out on Tests

Too few women at high risk for osteoporosis are being tested for the condition, while too many women at low risk are being screened.

Higher Altitude May Up SIDS Risk

Odds found to be doubled, though still very rare even at greater altitudes